Correlation Between Travere Therapeutics and CorMedix

Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and CorMedix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and CorMedix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Travere Therapeutics and CorMedix, you can compare the effects of market volatilities on Travere Therapeutics and CorMedix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of CorMedix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and CorMedix.

Diversification Opportunities for Travere Therapeutics and CorMedix

0.2

Correlation Coefficient

Travere Therapeutics  CorMedix

Modest diversification

The 3 months correlation between Travere and CorMedix is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and CorMedix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CorMedix and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with CorMedix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CorMedix has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and CorMedix go up and down completely randomly.

Pair Corralation between Travere Therapeutics and CorMedix

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 0.58 times more return on investment than CorMedix. However, Travere Therapeutics is 1.74 times less risky than CorMedix. It trades about 0.07 of its potential returns per unit of risk. CorMedix is currently generating about -0.01 per unit of risk. If you would invest  1,732  in Travere Therapeutics on December 30, 2024 and sell it today you would earn a total of  236.00  from holding Travere Therapeutics or generate 13.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Travere Therapeutics  vs.  CorMedix

Travere Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

CorMedix

Risk-Adjusted Performance

Very Weak

Over the last 90 days CorMedix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, CorMedix is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Travere Therapeutics and CorMedix

The main advantage of trading using opposite Travere Therapeutics and CorMedix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, CorMedix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CorMedix will offset losses from the drop in CorMedix's long position.

The idea behind Travere Therapeutics and CorMedix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.